StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — Akshay Bhagwat, JM Financial

BUYEmcure Pharmaceuticals Limited
Emcure Pharmaceuticals share price target & all analyst calls

byAkshay Bhagwat, JM FinancialHorizon: 1–3 months8 Apr 2026via Business Today

Entry₹1,572Inferred
Target₹1,750
Total upside +11.32% (call closed)
Stop loss₹1,500-4.58% risk
Exit₹1,50021 Apr 2026, 12:00 am
Stop-loss hit-4.58%
Follow Akshay Bhagwat for new calls(47% target hit, 45 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 45 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 12:36 am IST
2 supporting0 opposing
Supports the BUY call (2)

1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·15 Apr · 5d ago

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·5 Feb · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Emcure Pharmaceuticals

All analyst calls on Emcure Pharmaceuticals

More from Akshay Bhagwat, JM Financial

Every call and its outcome